IMUX ▲ +0.4% - Immunic, Inc.
$IMUX IMUX - Immunic Presents New Clinical, Biomarker, and Preclinical Data for Vidofludimus Calcium in Four Poster Presentations at MSToronto2026 - the 10th Joint ACTRIMS-ECTRIMS Meeting
21-OCT-2026 07:01 AM ET
Share this post
More filings for $IMUX
IMUX ▼ -1.0% - Immunic, Inc.Oct 19, 2026IMUX ▲ +1.4% - Immunic, Inc.Oct 7, 2026IMUX ▲ +3.2% - Immunic, Inc.Sep 2, 2026IMUX - Immunic, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026IMUX - Immunic, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026IMUX - Immunic, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026
View full $IMUX filing history →💬 Comments
Loading comments…
Leave a comment